Holen Sie sich die Stockscreener-App
2.55
1.19%
0.03
Vorhandelsmarkt:
2.57
0.02
+0.78%
Schlusskurs vom Vortag:
$2.52
Offen:
$2.53
24-Stunden-Volumen:
1.10M
Relative Volume:
0.73
Marktkapitalisierung:
$189.56M
Einnahmen:
$6.96M
Nettoeinkommen (Verlust:
$-46.51M
KGV:
-14.86
EPS:
-0.1716
Netto-Cashflow:
$-37.99M
1W Leistung:
+15.38%
1M Leistung:
+14.86%
6M Leistung:
-25.66%
1J Leistung:
-30.14%
1-Tages-Spanne:
$2.445
$2.595
1-Wochen-Bereich:
$2.17
$2.595
52-Wochen-Spanne:
$1.60
$5.3881
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Vergleichen Sie CATX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
2.55 | 187.33M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Fortgesetzt | Truist | Buy |
| 2025-10-10 | Eingeleitet | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) Receives Average Rating of “Buy” from Brokerages - Defense World
Perspective Therapeutics Inc (CATX) Performance and Fundamentals Dashboard tells a completely different story - Setenews
What Is the Future of Remi Edelstahl Tubulars Limited Stock Expert Projections ExplainedCapital Gains Strategies & Maximize Gains Professionally - earlytimes.in
DHP India Limited Included in Top Momentum ScanRetail Trading Trends & Consistent Double Returns - earlytimes.in
What analysts say about Perspective Therapeutics Inc AAJ0 stockMorning Star Patterns & Download Your Free Wealth Map PDF - earlytimes.in
Affinity Asset Advisors LLC Decreases Holdings in Perspective Therapeutics, Inc. $CATX - Defense World
Perspective Therapeutics (NASDAQ: CATX) sees FMR disclose 0.4% stake - Stock Titan
Can Perspective Therapeutics Inc. stock sustain breakout momentumQuarterly Portfolio Report & High Accuracy Trade Signal Alerts - Newser
CATX SEC FilingsPerspective Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Perspective Therapeutics Announces Acceptance of VMT-α-NET - GlobeNewswire
How Perspective Therapeutics Inc. stock moves on employment dataEarnings Recap Summary & Growth-Oriented Investment Plans - Newser
Can Perspective Therapeutics Inc. stock ride next bull market cycle2025 Analyst Calls & AI Enhanced Trade Execution Alerts - Newser
Is Perspective Therapeutics Inc. stock attractive for growth fundsWeekly Trend Summary & Weekly Watchlist for Consistent Profits - Newser
How Perspective Therapeutics Inc. stock reacts to oil pricesGlobal Markets & Expert Curated Trade Setup Alerts - Newser
How Perspective Therapeutics Inc. stock compares with market leadersQuarterly Trade Summary & Long-Term Safe Return Strategies - Newser
Why Perspective Therapeutics Inc. (AAJ0) stock is listed among top recommendationsWeekly Trend Report & Technical Entry and Exit Tips - Newser
What downside risks could hit Perspective Therapeutics Inc. (AAJ0) stockBull Run & Verified Stock Trade Ideas - Newser
How Perspective Therapeutics Inc. stock reacts to stronger dollarWeekly Risk Summary & Capital Efficient Trading Techniques - Newser
Does Perspective Therapeutics Inc. (AAJ0) stock trade below intrinsic value2025 Valuation Update & Risk Controlled Stock Pick Alerts - Newser
Perspective Therapeutics Updates Corporate Presentation on Advancements - TipRanks
[8-K] Perspective Therapeutics, Inc. Reports Material Event | CATX SEC FilingForm 8-K - Stock Titan
Perspective Therapeutics (CATX) 10K Form and SEC Filings 2025 - MarketBeat
Check out these key findings about Perspective Therapeutics Inc (CATX) - Setenews
Perspective Therapeutics (NASDAQ:CATX) Coverage Initiated by Analysts at Truist Financial - MarketBeat
EBIT per share of Perspective Therapeutics, Inc. – BER:AAJ0 - TradingView
CATX: Truist Securities Raises Price Target to $12.00 with Buy R - GuruFocus
Perspective Therapeutics (CATX) Stock Price, News & Analysis - MarketBeat
Perspective Therapeutics Inc Stock Analysis and ForecastMonthly Performance Summary & Bull Bear Market Updates - earlytimes.in
UBS Maintains Perspective Therapeutics (CATX) Buy Recommendation - Nasdaq
Perspective Therapeutics (CATX): UBS Maintains Rating but Lowers Price Target | CATX Stock News - GuruFocus
UBS lowers Perspective Therapeutics stock price target on competition concerns - Investing.com Nigeria
UBS lowers Perspective Therapeutics stock price target on competition concerns By Investing.com - Investing.com South Africa
Will Perspective Therapeutics Inc. stock outperform global peersQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Why Perspective Therapeutics Inc. stock could rally stronglyEarnings Summary Report & Risk Managed Investment Signals - newser.com
Is Perspective Therapeutics Inc. stock attractive for hedge fundsJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Is Perspective Therapeutics Inc. stock attractive post correction2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Perspective Therapeutics FY2025 EPS Cut by B. Riley - MarketBeat
B. Riley Expects Lower Earnings for Perspective Therapeutics - Defense World
What machine learning models say about Perspective Therapeutics Inc.Weekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
CATXPerspective Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
How geopolitical risks impact Perspective Therapeutics Inc. (AAJ0) stockJuly 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
Perspective Therapeutics to Participate in Upcoming December Conferences - The Manila Times
Perspective Therapeutics, Inc. Announces Participation in Upcoming Healthcare Conferences for Investor Engagement - Quiver Quantitative
Can Perspective Therapeutics Inc. stock attract ESG investmentsWall Street Watch & Verified Momentum Stock Watchlist - newser.com
Will Perspective Therapeutics Inc. stock beat value stocks2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Will Perspective Therapeutics Inc. (AAJ0) stock keep high P E multiplesTrade Signal Summary & High Accuracy Trade Alerts - newser.com
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
Kapitalisierung:
|
Volumen (24h):